Physician profile
Andreia Moraes
NPI 1851505119
$3,851.92
in general payments reported to CMS, 2019-2025
16 companies · $1,720 in 2025
The $1,720 reported for 2025 was more than what 94% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $437 · 2020: $229 · 2021: $210 · 2022: $242 · 2023: $150 · 2024: $864 · 2025: $1,720.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $2,400 · Food and Beverage: $334.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $2,400.00 |
| Food and Beverage | $333.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $2,400.00 | 2024-2025 | Bovine Collagen |
| Abbvie INC. | $404.81 | 2019-2022 | |
| Exeltis, USA INC. | $212.35 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $158.07 | 2023-2025 | |
| Therapeuticsmd, INC. | $149.20 | 2019-2022 | |
| Hologic Sales and Service, LLC | $133.89 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Pacira Pharmaceuticals Incorporated | $100.00 | 2019 | |
| Shield Therapeutics INC | $85.16 | 2022-2024 | Accrufer |
| Bayer Healthcare Pharmaceuticals INC. | $64.58 | 2020-2024 | |
| Agile Therapeutics, INC. | $38.54 | 2021-2022 | |
| Astellas Pharma US INC | $27.38 | 2023 | Veozah |
| Organon LLC | $20.15 | 2022 | |
| Mylan Pharmaceuticals INC. | $18.73 | 2019 | |
| Currax Pharmaceuticals LLC | $15.07 | 2021 | |
| Avion Pharmaceuticals | $12.72 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andreia Moraes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.